20 LATEST RESOURCES (155 INDEXED)
×
Schizophrenia and Glutathione: A Challenging Story · October 2023
Articles
Journal of Personalized Medicine
×
The Gut–Brain Axis in Schizophrenia: The Implications of the Gut Microbiome and SCFA Production · October 2023
Articles
Nutrients
×
Analysis of Polyunsaturated Fatty Acids in Antipsychotic-Free Individuals with At-Risk Mental State and Patients with First-Episode Schizophrenia · July 2023
Articles
Frontiers in Psychiatry
×
Meta-Analytic Evidence of Elevated Choline, Reduced N-Acetylaspartate, and Normal Creatine in Schizophrenia and Their Moderation by Measurement Quality, Echo Time, and Medication Status · June 2023
Articles
NeuroImage: Clinical
×
Evaluating the Effect of Melatonin on Positive and Negative Symptoms of Schizophrenic Patients: A Randomized Placebo-Controlled Study · April 2023
Articles
Iranian Journal of Psychiatry
×
Cognitive and Negative Symptoms in Schizophrenia with L-Carnosine Adjuvant Therapy – A Randomized Double-Blind Placebo-Controlled Study · March 2023
Articles
Pharmacology Research and Perspectives
×
Impact of a Caffeine Restriction Policy on Inpatients with Schizophrenia: A Pre-Post Comparison Using Electronic Health Records · March 2023
Abstracts
Journal of Clinical Psychopharmacology
×
Association between Arachidonic Acid and the Risk of Schizophrenia: A Cross-National Study and Mendelian Randomization Analysis · February 2023
Articles
Nutrients
×
a-Lipoic Acid as Adjunctive Treatment for Schizophrenia: A Randomized Double-Blind Study · January 2023
Abstracts
Journal of Clinical Psychopharmacology
×
Effect of Probiotic Adjuvant Therapy on Improvement of Clinical Symptoms and Interleukin 6 Levels in Patients with Schizophrenia · November 2022
Articles
Psychiatry Investigation
×
Effects of Omega-3 Polyunsaturated Fatty Acid Supplementation on Cognitive Functioning in Youth at Ultra-High Risk for Psychosis: Secondary Analysis of the NEURAPRO Randomised Controlled Trial · September 2022
Articles
BJPsych Open
×
Effect of Add-On Alpha Lipoic Acid on Psychopathology in Patients with Treatment-Resistant Schizophrenia: A Pilot Randomized Double-Blind Placebo-Controlled Trial · September 2022
Abstracts
Psychopharmacology
×
N-Acetylcysteine (NAC) in Schizophrenia Resistant to Clozapine: A Double-Blind, Randomized, Placebo-Controlled Trial Targeting Negative Symptoms · July 2022
Articles
Schizophrenia Bulletin
×
Probiotics Plus Dietary Fiber Supplements Attenuate Olanzapine-Induced Weight Gain in Drug-Naive First-Episode Schizophrenia Patients: Two Randomized Clinical Trials · May 2022
Articles
Schizophrenia Bulletin
×
EEG Microstates in Early Phase Psychosis: The Effects of Acute Caffeine Consumption · March 2022
Articles
Clinical EEG and Neuroscience
×
The Efficacy of Nutritional Supplements for the Adjunctive Treatment of Schizophrenia in Adults: A Systematic Review and Network Meta-Analysis · March 2022
Abstracts
Psychiatry Research
×
Sulforaphane Effects on Cognition and Symptoms in First and Early Episode Schizophrenia: A Randomized Double-Blind Trial · March 2022
Articles
Schizophrenia Bulletin Open
×
Alteration of Resting Electroencephalography by Acute Caffeine Consumption in Early Phase Psychosis · November 2021
Articles
Clinical EEG and Neuroscience